Insider Buying: Aditxt (NASDAQ:ADTX) Major Shareholder Purchases 4,252,767 Shares of Stock

Aditxt, Inc. (NASDAQ:ADTX) major shareholder Financial Lp Hrt bought 4,252,767 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were bought at an average cost of $0.02 per share, for a total transaction of $85,055.34. Following the transaction, the insider owned 2,459,308 shares in the company, valued at approximately $49,186.16. The trade was a -237.13% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Friday, June 5th, Financial Lp Hrt sold 735,462 shares of Aditxt stock. The shares were sold at an average price of $0.06, for a total value of $44,127.72.
• On Thursday, June 4th, Financial Lp Hrt bought 843,622 shares of Aditxt stock. The shares were bought at an average cost of $0.08 per share, for a total transaction of $67,489.76.
• On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The shares were sold at an average price of $7.56, for a total value of $8,232.84.
• On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The shares were sold at an average price of $7.83, for a total value of $1,104.03.
• On Tuesday, April 21st, Financial Lp Hrt bought 2,700 shares of Aditxt stock. The shares were bought at an average cost of $8.91 per share, for a total transaction of $24,057.00.
• On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The shares were sold at an average price of $8.10, for a total value of $3,588.30.

Aditxt Trading Up 3.9%

Shares of NASDAQ ADTX traded up $0.00 during trading hours on Tuesday, hitting $0.01. 471,683,418 shares of the company traded hands, compared to its average volume of 36,197,617. The stock has a market capitalization of $10,988.00, a price-to-earnings ratio of 0.00 and a beta of 0.84. The company’s 50 day moving average price is $5.02 and its 200 day moving average price is $140.79. Aditxt, Inc. has a 12 month low of $0.01 and a 12 month high of $53,451.08.

Aditxt (NASDAQ:ADTX) last released its earnings results on Tuesday, March 31st. The company reported $315,563.31 earnings per share for the quarter. Aditxt had a negative return on equity of 374.60% and a negative net margin of 360,152.50%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on ADTX shares. Wall Street Zen upgraded Aditxt to a “sell” rating in a report on Saturday, May 23rd. Weiss Ratings restated a “sell (e+)” rating on shares of Aditxt in a report on Monday, April 20th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.

About Aditxt

Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.

The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.